According to the NOF guidelines, pharmacologic treatment for osteoporosis should be initiated in postmenopausal women and men ≥ 50 years of age with low bone mass (T-score between -1.0 and -2.5, osteopenia) at the femoral neck, total hip, or lumbar spine by DEXA; and in patients with a 10-year hip fracture probability rate ≥ 3%, based on the US-adapted WHO absolute fracture risk model.
Other indications for pharmacologic therapy include hip or vertebral fractures or T-scores ≤ -2.5 at the femoral neck, total hip, or lumbar spine by DEXA.
Learn more about the treatment of osteoporosis.
Medscape © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Herbert S. Diamond. Fast Five Quiz: Do You Know Best Practices for Osteoporosis? - Medscape - Nov 12, 2020.